158 related articles for article (PubMed ID: 32842026)
21. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time.
Ma J; Liu L; Che G; Yu N; Dai F; You Z
BMC Cancer; 2010 Mar; 10():112. PubMed ID: 20338029
[TBL] [Abstract][Full Text] [Related]
22. M2-macrophage infiltration and macrophage traits of tumor cells in urinary bladder cancer.
Aljabery F; Olsson H; Gimm O; Jahnson S; Shabo I
Urol Oncol; 2018 Apr; 36(4):159.e19-159.e26. PubMed ID: 29288002
[TBL] [Abstract][Full Text] [Related]
23. A reappraisal of macrophage polarization in glioblastoma: Histopathological and immunohistochemical findings and review of the literature.
Mignogna C; Signorelli F; Vismara MF; Zeppa P; Camastra C; Barni T; Donato G; Di Vito A
Pathol Res Pract; 2016 Jun; 212(6):491-9. PubMed ID: 27101800
[TBL] [Abstract][Full Text] [Related]
24. Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment.
Sakakura K; Takahashi H; Kaira K; Toyoda M; Murata T; Ohnishi H; Oyama T; Chikamatsu K
Lab Invest; 2016 Sep; 96(9):994-1003. PubMed ID: 27322955
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
[TBL] [Abstract][Full Text] [Related]
26. Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer.
Jeong H; Hwang I; Kang SH; Shin HC; Kwon SY
J Breast Cancer; 2019 Mar; 22(1):38-51. PubMed ID: 30941232
[TBL] [Abstract][Full Text] [Related]
27. Combining UBR5 and CD163
Wang C; Hong T; Wang Y; Peng G; Yu Y; Zhang J; Zhuo D; Zheng J; Ma X; Cui X
Cancer Immunol Immunother; 2021 Oct; 70(10):2925-2935. PubMed ID: 33710368
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Role of Tumor-Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma.
Hori Y; Kubota A; Yokose T; Furukawa M; Matsushita T; Katsumata N; Oridate N
Laryngoscope; 2021 Nov; 131(11):2512-2518. PubMed ID: 33955550
[TBL] [Abstract][Full Text] [Related]
29. Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma.
Lisi L; Ciotti GM; Braun D; Kalinin S; Currò D; Dello Russo C; Coli A; Mangiola A; Anile C; Feinstein DL; Navarra P
Neurosci Lett; 2017 Apr; 645():106-112. PubMed ID: 28259657
[TBL] [Abstract][Full Text] [Related]
30. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
[TBL] [Abstract][Full Text] [Related]
31. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer.
Edin S; Wikberg ML; Dahlin AM; Rutegård J; Öberg Å; Oldenborg PA; Palmqvist R
PLoS One; 2012; 7(10):e47045. PubMed ID: 23077543
[TBL] [Abstract][Full Text] [Related]
32. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.
Barros MH; Segges P; Vera-Lozada G; Hassan R; Niedobitek G
PLoS One; 2015; 10(5):e0124531. PubMed ID: 25978381
[TBL] [Abstract][Full Text] [Related]
33. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y
Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392
[TBL] [Abstract][Full Text] [Related]
34. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
[TBL] [Abstract][Full Text] [Related]
35. Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment.
Ciucci A; Zannoni GF; Buttarelli M; Martinelli E; Mascilini F; Petrillo M; Ferrandina G; Scambia G; Gallo D
Oncotarget; 2016 Oct; 7(42):68033-68043. PubMed ID: 27462782
[TBL] [Abstract][Full Text] [Related]
36. Stromal categorization in early oral tongue cancer.
Almangush A; Bello IO; Heikkinen I; Hagström J; Haglund C; Kowalski LP; Nieminen P; Coletta RD; Mäkitie AA; Salo T; Leivo I
Virchows Arch; 2021 May; 478(5):925-932. PubMed ID: 32955604
[TBL] [Abstract][Full Text] [Related]
37. Accumulation of CD11c+CD163+ Adipose Tissue Macrophages through Upregulation of Intracellular 11β-HSD1 in Human Obesity.
Nakajima S; Koh V; Kua LF; So J; Davide L; Lim KS; Petersen SH; Yong WP; Shabbir A; Kono K
J Immunol; 2016 Nov; 197(9):3735-3745. PubMed ID: 27698011
[TBL] [Abstract][Full Text] [Related]
38. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.
Helm O; Held-Feindt J; Grage-Griebenow E; Reiling N; Ungefroren H; Vogel I; Krüger U; Becker T; Ebsen M; Röcken C; Kabelitz D; Schäfer H; Sebens S
Int J Cancer; 2014 Aug; 135(4):843-61. PubMed ID: 24458546
[TBL] [Abstract][Full Text] [Related]
39. M2-like macrophage polarization in high lactic acid-producing head and neck cancer.
Ohashi T; Aoki M; Tomita H; Akazawa T; Sato K; Kuze B; Mizuta K; Hara A; Nagaoka H; Inoue N; Ito Y
Cancer Sci; 2017 Jun; 108(6):1128-1134. PubMed ID: 28370718
[TBL] [Abstract][Full Text] [Related]
40. Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients.
Liu H; Wang J; Zhang M; Xuan Q; Wang Z; Lian X; Zhang Q
Breast Cancer Res Treat; 2017 Nov; 166(1):95-107. PubMed ID: 28730338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
